Loading clinical trials...
Loading clinical trials...
A prospective, randomized, double-masked study that evaluated the ocular efficacy and safety of two doses of the EYP-1901 intravitreal (IVT) insert compared to sham.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
NCT03197870 · Nonproliferative Diabetic Retinopathy
NCT02718326 · Nonproliferative Diabetic Retinopathy
NCT02834663 · Nonproliferative Diabetic Retinopathy
EyePoint Investigative Site
Phoenix, Arizona
EyePoint Investigative Site
Huntington Beach, California
EyePoint Investigative Site
Oxnard, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions